| Literature DB >> 24971148 |
Shirley S M Fong1, Shamay S M Ng2, W S Luk3, Louisa M Y Chung4, Janet Y H Wong5, Joanne W Y Chung4.
Abstract
This study aimed to investigate the effects of Qigong intervention on quality of life (QOL), health-related functioning, and cancer-related symptoms in survivors of nasopharyngeal cancer (NPC). Twenty-five survivors of NPC were included in the experimental group (mean age ± SD: 55.4 ± 7.5 years) and 27 in the control group (mean age ± SD: 58.7 ± 9.5 years). The experimental group underwent a weekly 1.5-hour Qigong training program and an identical home program (three times/week) for six months. The control group received no training. Global health status/QOL, functioning, and cancer-related symptoms were assessed by the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-H&N35 questionnaires before training began, after three months of Qigong training, at the end of the six-month Qigong intervention (i.e., posttest), and six months posttest. Intention-to-treat analysis revealed no statistically (P > 0.05) or clinically significant improvement in global health status/QOL, functioning, or symptoms in either group. The experimental group had 45.8% fewer sense-related (smell and taste) problems (P < 0.05) but 98.6% more speech-related problems (P < 0.05) than the control group after the Qigong intervention. Qigong training resulted in no apparent improvement in health-related QOL, functionality, or cancer-related symptoms in cancer-free survivors of NPC, except for a possible reduction in smell- and taste-related problems.Entities:
Year: 2014 PMID: 24971148 PMCID: PMC4058151 DOI: 10.1155/2014/495274
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Qigong exercise protocol.
| Exercise type | Duration |
|---|---|
| Warm-up: jogging | 5 minutes |
| 18 Forms Tai Chi Internal Qigong [ | 40 minutes |
| (1) Raising the arms and pressing down | |
| (2) Opening the chest | |
| (3) Painting a rainbow from side to side | |
| (4) Separating the clouds with two arms | |
| (5) Rolling the arms in a horse-riding stance | |
| (6) Rowing the boat | |
| (7) Carrying a ball in front of the shoulders | |
| (8) Turning around to look at the moon | |
| (9) Twisting the waist and pushing the palms | |
| (10) Cloud hands in a horse-riding stance | |
| (11) Scooping the sea and searching the sky | |
| (12) Pushing waves in walking stance | |
| (13) Flying dove spreads its wings | |
| (14) Punching in horse stance | |
| (15) Flying like wild geese | |
| (16) Rotating a flying wheel | |
| (17) Stepping whilst bouncing a ball | |
| (18) Pressing down to balance the chi | |
| Additional NPC-targeted exercises | 40 minutes |
| (1) Arms cross in front and curl up the body | |
| (2) Place hands behind the neck | |
| (3) Olfactory stimulation (e.g., breathe in slowly | |
| (4) Inner ear stimulation (e.g., different head and neck | |
| (5) Oral and swallowing exercise (e.g., use the tip of the | |
| (6) Mouth-opening exercise and make sounds with | |
| Cooldown: gentle whole-body stretching | 5 minutes |
Characteristics of participants measured at baseline.
| Qigong group | Control group |
| |
|---|---|---|---|
| Age (year) | 55.4 ± 7.5 | 58.7 ± 9.5 | 0.172 |
| Sex (number of male : female) | 12 : 13 | 16 : 11 | 0.416 |
| Weight (kg) | 59.5 ± 15.1 | 56.8 ± 10.5 | 0.451 |
| Height (cm) | 163.2 ± 9.1 | 161.5 ± 8.1 | 0.496 |
| Body mass index (kg/m2) | 22.3 ± 5.0 | 21.7 ± 3.3 | 0.640 |
| Reported NPC stage at diagnosis [ | |||
| Stage I ( | 5 (20%) | 2 (7.4%) | |
| Stage II ( | 5 (20%) | 7 (25.9%) | |
| Stage III ( | 11 (44%) | 15 (55.6%) | |
| Stage IV ( | 4 (16%) | 3 (11.1%) | |
| Post-NPC duration (year) | 12.5 ± 7.1 | 8.4 ± 9.7 | 0.094 |
| Previous NPC treatment | |||
| Radiotherapy ( | 17 (68%) | 9 (33.3%) | |
| Radiotherapy and | 7 (28%) | 18 (66.6%) | |
| Radiotherapy, | 1 (4%) | 0 (0%) | |
| Habitual physical activity level (metabolic equivalent hours per week) | 13.9 ± 14.1 | 14.9 ± 14.5 | 0.795 |
Mean ± standard deviation presented for continuous variables.
*P < 0.05 for between-group comparisons.
EORTC scores measured at four time points.
| Qigong group ( | Control group ( | Group × time interaction | Group effect | Time effect | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Mid | Post | FU | Pre | Mid | Post | FU | Effect size |
| Effect size |
| Effect size |
| |
| EORTC QLQ-C30 | ||||||||||||||
| Global health status/QOL | 61.81 ± 22.10 | 63.19 ± 24.32 | 61.81 ± 26.57 | 66.67 ± 27.47 | 58.65 ± 21.01 | 62.50 ± 18.30 | 66.03 ± 18.55a | 67.95 ± 16.45a | 0.143 | 0.067 | <0.001 | 0.945 | 0.213 | 0.011* |
| Functional scales (higher scores = higher functions) | 0.387 | 0.189 | 0.143 | 0.221 | 0.410 | 0.134 | ||||||||
| Physical functioning | 78.06 ± 16.85 | 80.56 ± 15.22 | 79.17 ± 13.94 | 78.89 ± 15.06 | 76.67 ± 13.10 | 78.72 ± 12.22 | 77.18 ± 12.53 | 77.44 ± 13.21 | ||||||
| Role functioning | 80.56 ± 22.88 | 81.25 ± 21.03 | 84.03 ± 21.69 | 86.11 ± 21.80 | 87.18 ± 19.04 | 86.54 ± 18.27 | 85.90 ± 18.07 | 84.62 ± 21.56 | ||||||
| Emotional | 76.74 ± 19.19 | 79.51 ± 19.35 | 78.13 ± 20.24 | 81.60 ± 18.39 | 77.24 ± 20.35 | 76.28 ± 18.96 | 78.53 ± 19.32 | 80.45 ± 18.40 | ||||||
| Cognitive | 65.97 ± 23.30 | 65.28 ± 20.21 | 68.75 ± 24.23 | 69.44 ± 21.23 | 69.23 ± 24.81 | 67.95 ± 26.63 | 72.44 ± 22.58 | 69.87 ± 24.50 | ||||||
| Social functioning | 74.31 ± 25.53 | 75.69 ± 26.00 | 77.08 ± 27.72 | 79.86 ± 26.46 | 86.54 ± 18.87 | 87.18 ± 17.20 | 85.90 ± 16.12 | 83.33 ± 17.00 | ||||||
| Symptom scales (higher scores = more symptoms) | 0.667 | 0.123 | 0.190 | 0.425 | 0.659 | 0.140 | ||||||||
| Fatigue | 37.50 ± 20.67 | 36.11 ± 18.89 | 34.72 ± 20.54 | 33.80 ± 21.85 | 35.47 ± 18.06 | 34.19 ± 17.76 | 38.03 ± 17.26 | 35.47 ± 19.88 | ||||||
| Nausea and vomiting | 6.94 ± 12.93 | 5.56 ± 11.70 | 4.17 ± 10.13 | 4.17 ± 10.13 | 5.13 ± 11.32 | 5.13 ± 11.32 | 5.13 ± 11.32 | 5.77 ± 11.49 | ||||||
| Pain | 32.64 ± 24.81 | 31.94 ± 23.01 | 29.86 ± 24.07 | 25.69 ± 24.56 | 25.64 ± 20.13 | 24.36 ± 19.57 | 26.92 ± 18.90 | 27.56 ± 18.82 | ||||||
| Dyspnea | 31.94 ± 25.02 | 29.17 ± 20.41 | 23.61 ± 20.80 | 23.61 ± 20.80 | 26.92 ± 24.98 | 23.08 ± 20.59 | 24.36 ± 22.23 | 25.64 ± 21.72 | ||||||
| Insomnia | 29.17 ± 22.66 | 27.78 ± 27.22 | 26.39 ± 25.97 | 20.83 ± 21.56 | 34.62 ± 30.52 | 33.33 ± 31.27 | 43.59 ± 32.34 | 42.31 ± 34.71 | ||||||
| Appetite loss | 25.00 ± 28.23 | 22.22 ± 28.94 | 18.06 ± 25.97 | 15.28 ± 25.97 | 12.82 ± 19.04 | 14.10 ± 21.44 | 15.38 ± 23.53 | 12.82 ± 23.24 | ||||||
| Constipation | 15.28 ± 21.93 | 20.83 ± 23.70 | 19.44 ± 27.66 | 15.28 ± 24.04 | 21.79 ± 22.98 | 17.95 ± 19.39 | 17.95 ± 21.56 | 14.10 ± 19.26 | ||||||
| Diarrhea | 15.28 ± 19.61 | 8.33 ± 14.74 | 9.72 ± 18.33 | 12.50 ± 19.19 | 12.82 ± 19.04 | 14.10 ± 19.26 | 14.10 ± 21.44 | 11.54 ± 18.72 | ||||||
| Financial difficulties | 26.39 ± 31.05 | 26.39 ± 32.57 | 20.83 ± 33.78 | 19.44 ± 32.48 | 12.82 ± 19.04 | 14.10 ± 19.26 | 15.38 ± 16.95 | 17.95 ± 19.39 | ||||||
|
| ||||||||||||||
| EORTC QLQ-H&N35 | ||||||||||||||
| Symptom scales (higher scores = more symptoms) | 0.804 | 0.317 | 0.572 | 0.003* | 0.804 | 0.317 | ||||||||
| Pain | 12.68 ± 13.02 | 12.68 ± 13.73 | 14.13 ± 16.94 | 10.87 ± 12.67 | 17.75 ± 24.27 | 19.20 ± 17.84 | 19.20 ± 16.56 | 18.48 ± 16.47 | ||||||
| Swallowing | 34.03 ± 25.05 | 31.94 ± 26.66 | 34.38 ± 25.81 | 34.72 ± 24.90 | 29.32 ± 18.69 | 28.70 ± 17.95 | 28.09 ± 17.01 | 26.23 ± 16.13 | ||||||
| Sense problems | 22.22 ± 18.82 | 21.53 ± 17.36b | 18.75 ± 17.93b | 16.67 ± 14.74b | 33.95 ± 28.67 | 35.80 ± 26.03 | 34.57 ± 26.52 | 33.95 ± 25.94 | ||||||
| Speech problems | 29.17 ± 24.91 | 28.24 ± 25.38b | 27.78 ± 25.80b | 23.61 ± 23.47 | 18.52 ± 22.85 | 14.81 ± 19.49 | 13.99 ± 19.14 | 12.76 ± 18.92 | ||||||
| Trouble with social | 39.24 ± 32.37 | 36.81 ± 31.94 | 35.07 ± 33.24 | 33.33 ± 32.88 | 27.78 ± 29.87 | 25.93 ± 25.04 | 27.47 ± 24.11 | 25.62 ± 24.88 | ||||||
| Trouble with social | 21.45 ± 24.37 | 19.13 ± 21.40 | 18.84 ± 23.32 | 16.81 ± 22.64 | 12.46 ± 20.03 | 13.33 ± 19.07 | 9.28 ± 18.83 | 9.57 ± 19.47 | ||||||
| Less sexuality | 39.86 ± 33.99 | 36.23 ± 30.84 | 34.06 ± 30.76 | 39.86 ± 34.36 | 35.51 ± 29.86 | 42.03 ± 30.51 | 46.38 ± 34.07 | 46.38 ± 34.07 | ||||||
| Teeth | 44.44 ± 27.22 | 38.89 ± 23.40 | 37.50 ± 28.34 | 38.89 ± 27.22 | 39.51 ± 30.71 | 34.57 ± 31.33 | 38.27 ± 32.95 | 43.21 ± 33.10 | ||||||
| Opening mouth | 36.11 ± 30.95 | 30.56 ± 30.95 | 33.33 ± 31.08 | 31.94 ± 30.26 | 28.40 ± 30.25 | 32.10 ± 32.66 | 34.57 ± 32.66 | 32.10 ± 29.93 | ||||||
| Dry mouth | 65.28 ± 25.02 | 56.94 ± 23.01 | 55.56 ± 23.40 | 55.56 ± 23.40 | 62.96 ± 29.72 | 61.73 ± 28.80 | 62.96 ± 28.24 | 56.79 ± 30.40 | ||||||
| Sticky saliva | 44.44 ± 32.10 | 38.89 ± 30.56 | 38.89 ± 30.56 | 38.89 ± 30.56 | 48.15 ± 36.20 | 50.62 ± 35.05 | 50.62 ± 28.30 | 50.62 ± 31.17 | ||||||
| Coughing | 25.00 ± 22.52 | 23.61 ± 23.01 | 25.00 ± 24.57 | 25.00 ± 24.57 | 29.63 ± 31.12 | 19.75 ± 24.91 | 17.28 ± 16.97 | 18.52 ± 19.25 | ||||||
| Felt ill | 33.33 ± 20.60 | 28.99 ± 25.23 | 24.64 ± 27.00 | 24.64 ± 25.06 | 30.43 ± 28.27 | 31.88 ± 30.94 | 36.23 ± 28.27 | 33.33 ± 22.47 | ||||||
Pre: pretest (baseline); mid: midintervention test (3 months); post: posttest (6 months); FU: follow-up test (12 months).
Mean ± SD presented the continuous variables.
The effect sizes are in partial eta-squared.
Group-by-time interaction, group and time effects.
*Significant difference at P < 0.05.
Within group (alpha adjusted to 0.008 due to six paired comparisons).
aSignificant difference at P < 0.008 compared with the pretest values.
Between groups.
bDifference significant at P < 0.05 compared with the control group.